Insider Buying 03-28-25 Stagflation is the Game. Confidence has been Shattered

The market as measured by the S&P 500 shed 1.53% last month. The dollar was down, gold up. There seems be a pattern here. Money is voting in real time and it’s leaving the stock market.  This looks to me like the opposite of a virtuous cycle. Instead, a vicious cycle is developing a loop of negative events that reinforce and worsen each other. I suspect as the quarter ends, there will be a steady drum beat of lowered earnings expectations.   Consumer confidence is falling at historic rates and business animal spirits are retreating with their tails between their legs. … Read more

Quiet Insider Buying Shortened Week May 29th 2020

Jazz Pharmaceutical Director Seamus Mulligan bought 50,000 shares at $111.08. Before investors pile in behind that enforcement, it’s worth considering Mulligan bought 50,000 shares back in 11/15/18 at $144.56. JAZZ had a few analyst downgrades after releasing last quarter’s earnings report. JAZZ is a leader in sleep medicine and has a growing hematology/oncology portfolio. Dynavax Technologies DVAX is a startup biotech.  The priced a 14M share offering at $5 below the last closing price osf $5.66. Director Jack bought 1,000,000 shares at $5. Do you think he knew that DVAX would announce a week letter that Sky would report a … Read more